Published in Biometrika on April 01, 2009
Testing for improvement in prediction model performance. Stat Med (2013) 2.62
A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies. Biometrics (2009) 1.79
Joint modeling, covariate adjustment, and interaction: contrasting notions in risk prediction models and risk prediction performance. Epidemiology (2011) 1.67
Accommodating Covariates in ROC Analysis. Stata J (2009) 1.63
Biomarker evaluation and comparison using the controls as a reference population. Biostatistics (2008) 1.32
Development and evaluation of a genetic risk score for obesity. Biodemography Soc Biol (2013) 1.08
Development and evaluation of multi-marker risk scores for clinical prognosis. Stat Methods Med Res (2012) 0.93
ROC analysis in biomarker combination with covariate adjustment. Acad Radiol (2013) 0.91
Contrasting two frameworks for ROC analysis of ordinal ratings. Med Decis Making (2010) 0.87
Borrowing Information across Populations in Estimating Positive and Negative Predictive Values. J R Stat Soc Ser C Appl Stat (2011) 0.84
Covariate adjustment in estimating the area under ROC curve with partially missing gold standard. Biometrics (2013) 0.83
Estimating the receiver operating characteristic curve in studies that match controls to cases on covariates. Acad Radiol (2013) 0.81
Estimating improvement in prediction with matched case-control designs. Lifetime Data Anal (2013) 0.79
Validation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort Study. PLoS One (2015) 0.78
LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS. Ann Appl Stat (2013) 0.77
Evaluating and comparing biomarkers with respect to the area under the receiver operating characteristics curve in two-phase case-control studies. Biostatistics (2016) 0.75
Combining biomarkers for classification with covariate adjustment. Stat Med (2017) 0.75
A regression approach to ROC surface, with applications to Alzheimer's disease. Sci China Math (2012) 0.75
Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med (1992) 16.23
Phases of biomarker development for early detection of cancer. J Natl Cancer Inst (2001) 10.37
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
The LMS method for constructing normalized growth standards. Eur J Clin Nutr (1990) 6.89
The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst (2003) 3.08
The robustness of the "binormal" assumptions used in fitting ROC curves. Med Decis Making (1988) 3.02
Distribution-free ROC analysis using binary regression techniques. Biostatistics (2002) 2.64
An interpretation for the ROC curve and inference using GLM procedures. Biometrics (2000) 2.01
The analysis of placement values for evaluating discriminatory measures. Biometrics (2004) 1.93
Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics (2007) 1.88
Indices of discrimination or diagnostic accuracy: their ROCs and implied models. Psychol Bull (1986) 1.81
Semiparametric estimation of time-dependent ROC curves for longitudinal marker data. Biostatistics (2004) 1.14
The use of the 'binormal' model for parametric ROC analysis of quantitative diagnostic tests. Stat Med (1996) 1.14
Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection? Cancer Epidemiol Biomarkers Prev (2004) 1.02
Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med (2008) 5.05
Partial AUC estimation and regression. Biometrics (2003) 2.80
Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology (2014) 2.67
Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol (2008) 2.61
Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. J Natl Cancer Inst (2008) 2.14
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene (2005) 2.07
Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes. Biostatistics (2004) 1.98
Measuring the performance of markers for guiding treatment decisions. Ann Intern Med (2011) 1.95
Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics (2007) 1.88
Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction". Circulation (2007) 1.71
Joint modeling, covariate adjustment, and interaction: contrasting notions in risk prediction models and risk prediction performance. Epidemiology (2011) 1.67
Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome. J Am Stat Assoc (2008) 1.65
Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clin Trials (2006) 1.56
Endoscopic ultrasound, positron emission tomography, and computerized tomography for lung cancer. Am J Respir Crit Care Med (2003) 1.48
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context. Am J Epidemiol (2012) 1.45
Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. Stat Med (2004) 1.45
Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab (2004) 1.28
A framework for evaluating markers used to select patient treatment. Med Decis Making (2013) 1.25
An approach to evaluating and comparing biomarkers for patient treatment selection. Int J Biostat (2014) 1.18
Methods for Assessing Improvement in Specificity when a Biomarker is Combined with a Standard Screening Test. Stat Biopharm Res (2009) 1.13
Sample size calculations for comparative studies of medical tests for detecting presence of disease. Stat Med (2002) 1.07
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective. Ann Intern Med (2016) 0.92
Improving risk classification of critical illness with biomarkers: a simulation study. J Crit Care (2013) 0.87
Using the ROC curve for gauging treatment effect in clinical trials. Stat Med (2006) 0.79
LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS. Ann Appl Stat (2013) 0.77
Adopting nested case-control quota sampling designs for the evaluation of risk markers. Lifetime Data Anal (2013) 0.77